Bruker Co. (BRKR) Shares Bought by Bank of Montreal Can

Bank of Montreal Can lifted its stake in shares of Bruker Co. (NASDAQ:BRKR) by 1,244.3% in the third quarter, Holdings Channel reports. The fund owned 64,753 shares of the medical research company’s stock after acquiring an additional 59,936 shares during the quarter. Bank of Montreal Can’s holdings in Bruker were worth $2,166,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of BRKR. SG Americas Securities LLC bought a new stake in shares of Bruker during the 2nd quarter worth $101,000. Sun Life Financial INC bought a new stake in shares of Bruker during the 2nd quarter worth $163,000. Strs Ohio bought a new stake in shares of Bruker during the 2nd quarter worth $327,000. State of Alaska Department of Revenue lifted its holdings in shares of Bruker by 35.6% during the 2nd quarter. State of Alaska Department of Revenue now owns 11,510 shares of the medical research company’s stock worth $334,000 after acquiring an additional 3,020 shares during the last quarter. Finally, Quantitative Systematic Strategies LLC bought a new stake in shares of Bruker during the 2nd quarter worth $342,000. 64.86% of the stock is owned by institutional investors.

Bruker stock opened at $34.90 on Friday. The company has a quick ratio of 1.27, a current ratio of 2.22 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $5.24 billion, a price-to-earnings ratio of 28.84, a price-to-earnings-growth ratio of 2.04 and a beta of 1.34. Bruker Co. has a twelve month low of $28.13 and a twelve month high of $36.53.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings results on Thursday, November 1st. The medical research company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.07. The business had revenue of $466.60 million during the quarter, compared to the consensus estimate of $451.88 million. Bruker had a net margin of 5.24% and a return on equity of 27.96%. The firm’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the previous year, the firm posted $0.29 earnings per share. On average, equities analysts anticipate that Bruker Co. will post 1.4 EPS for the current fiscal year.

A number of analysts have recently issued reports on the stock. BidaskClub downgraded shares of Bruker from a “buy” rating to a “hold” rating in a report on Wednesday, September 19th. ValuEngine raised shares of Bruker from a “hold” rating to a “buy” rating in a report on Thursday. Morgan Stanley downgraded shares of Bruker from an “equal weight” rating to an “underweight” rating and lifted their price objective for the stock from $31.00 to $32.00 in a report on Thursday, September 20th. UBS Group assumed coverage on shares of Bruker in a report on Tuesday, October 9th. They set a “sell” rating and a $30.00 price objective for the company. They noted that the move was a valuation call. Finally, Zacks Investment Research downgraded shares of Bruker from a “hold” rating to a “sell” rating in a report on Tuesday, July 24th. Three research analysts have rated the stock with a sell rating, four have assigned a hold rating and three have issued a buy rating to the stock. Bruker currently has an average rating of “Hold” and a consensus price target of $34.63.

ILLEGAL ACTIVITY NOTICE: “Bruker Co. (BRKR) Shares Bought by Bank of Montreal Can” was reported by WKRB News and is owned by of WKRB News. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.wkrb13.com/2018/11/09/bruker-co-brkr-shares-bought-by-bank-of-montreal-can.html.

Bruker Company Profile

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies.

Recommended Story: Technical Analysis

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR).

Institutional Ownership by Quarter for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply